The average one-year price target for Fennec Pharmaceuticals (TSX:FRX) has been revised to $21.57 / share. This is an increase of 10.41% from the prior estimate of $19.53 dated November 16, 2025. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results